| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |